Literature DB >> 21412054

HIF-1α depletion results in SP1-mediated cell cycle disruption and alters the cellular response to chemotherapeutic drugs.

Carolyn Culver1, Andrew Melvin, Sharon Mudie, Sonia Rocha.   

Abstract

Hypoxia inducible factor (HIF) is the major transcription factor involved in the regulation of the cellular response to hypoxia, or low oxygen tensions. Even though HIF-1 function is mostly studied following hypoxic stress, well oxygenated areas of several diseased tissues have detectable levels of this transcription factor. Therefore, it is surprising how little is known about the function of HIF in normoxia. This study seeks to fill this gap. Using transient HIF-1α knockdown, as well as, stable cell lines generated using short hairpin RNAs (shRNA), we have further characterized the role of HIF-1α in normoxia. Our data reveals that knockdown of HIF-1α results in a significant increase in cells in the G1 phase of the cell cycle. We find that HIF-1α depletion increases the protein and mRNA of both p21 and p27. p21 is induced via, at least in part, p53-independent but SP1-dependent mechanisms. Interestingly, HIF-1α knockdown also alters the cellular response to chemotherapeutic agents. These data have important implications in not only for the further understanding of HIF-1α, a major transcription factor, but also for the use of HIF-targeted and combination therapies in cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21412054      PMCID: PMC3117135          DOI: 10.4161/cc.10.8.15326

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  60 in total

1.  Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase.

Authors:  A Görlach; I Diebold; V B Schini-Kerth; U Berchner-Pfannschmidt; U Roth; R P Brandes; T Kietzmann; R Busse
Journal:  Circ Res       Date:  2001-07-06       Impact factor: 17.367

2.  Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.

Authors:  H Zhong; K Chiles; D Feldser; E Laughner; C Hanrahan; M M Georgescu; J W Simons; G L Semenza
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

4.  Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.

Authors:  B H Jiang; G Jiang; J Z Zheng; Z Lu; T Hunter; P K Vogt
Journal:  Cell Growth Differ       Date:  2001-07

5.  Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line.

Authors:  K Nakano; T Mizuno; Y Sowa; T Orita; T Yoshino; Y Okuyama; T Fujita; N Ohtani-Fujita; Y Matsukawa; T Tokino; H Yamagishi; T Oka; H Nomura; T Sakai
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

6.  Inhibition of N-(4-hydroxyphenyl)retinamide-induced autophagy at a lower dose enhances cell death in malignant glioma cells.

Authors:  Meenakshi Tiwari; Virendra Kumar Bajpai; Amogh Anant Sahasrabuddhe; Ashok Kumar; Rohit Anthony Sinha; Sanjay Behari; Madan Madhav Godbole
Journal:  Carcinogenesis       Date:  2008-01-03       Impact factor: 4.944

7.  Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.

Authors:  Ryosuke Osada; Akiko Horiuchi; Norihiko Kikuchi; Junko Yoshida; Akiko Hayashi; Masao Ota; Yoshihiko Katsuyama; Giovanni Melillo; Giovanni Mellilo; Ikuo Konishi
Journal:  Hum Pathol       Date:  2007-06-06       Impact factor: 3.466

8.  Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells.

Authors:  Sandrine Lacour; Arlette Hammann; Solène Grazide; Dominique Lagadic-Gossmann; Anne Athias; Odile Sergent; Guy Laurent; Philippe Gambert; Eric Solary; Marie-Thérèse Dimanche-Boitrel
Journal:  Cancer Res       Date:  2004-05-15       Impact factor: 12.701

9.  Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis.

Authors:  J L Gervais; P Seth; H Zhang
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

10.  Mechanism of hypoxia-induced NF-kappaB.

Authors:  Carolyn Culver; Anders Sundqvist; Sharon Mudie; Andrew Melvin; Dimitris Xirodimas; Sonia Rocha
Journal:  Mol Cell Biol       Date:  2010-08-09       Impact factor: 4.272

View more
  16 in total

1.  HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells.

Authors:  Haojian Zhang; Huawei Li; Hualin S Xi; Shaoguang Li
Journal:  Blood       Date:  2012-01-24       Impact factor: 22.113

2.  Therapeutic efficacy of combined vaccination against tumor pericyte-associated antigens DLK1 and DLK2 in mice.

Authors:  Kellsye Paula L Fabian; Nina Chi-Sabins; Jennifer L Taylor; Ronald Fecek; Aliyah Weinstein; Walter J Storkus
Journal:  Oncoimmunology       Date:  2017-02-10       Impact factor: 8.110

3.  A guiding torch at the poles: the multiple roles of spindle microtubule-organizing centers during cell division.

Authors:  Ana M Rincón; Fernando Monje-Casas
Journal:  Cell Cycle       Date:  2020-05-13       Impact factor: 4.534

4.  A hypoxia-induced decrease of either MICA/B or Hsp70 on the membrane of tumor cells mediates immune escape from NK cells.

Authors:  Daniela Schilling; Fabian Tetzlaff; Sarah Konrad; Wei Li; Gabriele Multhoff
Journal:  Cell Stress Chaperones       Date:  2014-08-08       Impact factor: 3.667

5.  HIF-1α restricts NF-κB-dependent gene expression to control innate immunity signals.

Authors:  Daniel Bandarra; John Biddlestone; Sharon Mudie; H-Arno J Müller; Sonia Rocha
Journal:  Dis Model Mech       Date:  2014-12-15       Impact factor: 5.758

6.  Cezanne (OTUD7B) regulates HIF-1α homeostasis in a proteasome-independent manner.

Authors:  Anja Bremm; Sonia Moniz; Julia Mader; Sonia Rocha; David Komander
Journal:  EMBO Rep       Date:  2014-10-29       Impact factor: 8.807

Review 7.  Cell cycle progression in response to oxygen levels.

Authors:  Brian Ortmann; Jimena Druker; Sonia Rocha
Journal:  Cell Mol Life Sci       Date:  2014-05-25       Impact factor: 9.261

8.  PHD1 links cell-cycle progression to oxygen sensing through hydroxylation of the centrosomal protein Cep192.

Authors:  Sandra C Moser; Dalila Bensaddek; Brian Ortmann; Jean-Francois Maure; Sharon Mudie; J Julian Blow; Angus I Lamond; Jason R Swedlow; Sonia Rocha
Journal:  Dev Cell       Date:  2013-08-08       Impact factor: 12.270

9.  Targeting HIF2α translation with Tempol in VHL-deficient clear cell renal cell carcinoma.

Authors:  Carole Sourbier; Gaurav Srivastava; Manik C Ghosh; Sanchari Ghosh; Youfeng Yang; Gopal Gupta; William Degraff; Murali C Krishna; James B Mitchell; Tracey A Rouault; W Marston Linehan
Journal:  Oncotarget       Date:  2012-11

10.  Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma.

Authors:  Enrica Borsi; Giulia Perrone; Carolina Terragna; Marina Martello; Angela F Dico; Giancarlo Solaini; Alessandra Baracca; Gianluca Sgarbi; Gianandrea Pasquinelli; Sabrina Valente; Elena Zamagni; Paola Tacchetti; Giovanni Martinelli; Michele Cavo
Journal:  Oncotarget       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.